1Friedman AN, Hunsicker LG, Selhub J, et al. Clinical and nuitritianal correlates of C-reactive protein in type 2 diabetic nephropathy. Atherosclerosis,2004,172:121-125.
2Hashimoto H, Kitagawa K, Hougaku H, et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation, 2001,104: 63-67.
3Stehouwer CDA, Gall MA, Twisk JW, et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes,2002,51 : 1157-1165.
5Devaraj S, Xu DY, Jiala L. C-reactive protein increases plasm inogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation, 2003,107: 398-404.
6Sugimoto H, Shikata K, Wada J, et al. Advanced glycation end prnduetscytokine-nitric oxide sequence path way in the development of diabetic nephropathy: aminoguanidine a meliorates the over expression of tumor necrosis factor alpha and inducible nitric oxide synthase in diabetic rat glomeroli. Diabetologia, 1999,42: 878.
7Askari B, Ferreri NR. Regulation of prostacyclin synthesis by angiotensin Ⅱ and TNF-Alpha in vascular smooth muscle. Prostaglandins Other Lipid Mediat,2001,63:175-187.
5Brownlee M.Biochemistry and molecular cell biology of diabetic complications[J].Nature,2001,414(6865):813-820.
6Wei XF,Zhou QG,Hou FF,et al.Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase[J].Am J Physiol Renal Physiol,2009,296(2):F427-437.
7Shi XY,Hou FF,Niu HX,et al.Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase[J].Endocrinology,2008,149(4):1829-1839.
8Li HY,Hou FF,Zhang X,et al.Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model[J].J Am Soc Nephrol,2007,18(2):528-538.
9Hou FF,Xie D,Zhang X,et al.Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study:a randomized controlled study of benazepril and losartan in chronic renal insufficiency[J].J Am Soc Nephrol,2007,18(6):1889-1898.
10Ha H,Yu MR,Choi YJ,et al.Role of high glucose-induced nuclear factor-kappa B activation in monocyte chemoattractant protein-1 expression by mesangial cells[J].J Am Soc Nephrol,2002,13(14):894-902.
